Cite

HARVARD Citation

    Suciu, S. et al. (2018). Relapse-Free Survival as a Surrogate for Overall Survival in the Evaluation of Stage II–III Melanoma Adjuvant Therapy. Journal of the National Cancer Institute. p. . [Online]. 
  
Back to record